Literature DB >> 33989438

TP53 disruption as a risk factor in the era of targeted therapies: a multicenter retrospective study of 525 chronic lymphocytic leukemia cases.

Valter Gattei1, Massimo Gentile2, Fortunato Morabito3,4, Giovanni Del Poeta5, Francesca Romana Mauro6, Gianluigi Reda7, Paolo Sportoletti8, Luca Laurenti9, Marta Coscia10, Yair Herishanu11, Sabrina Bossio3, Marzia Varettoni12, Roberta Murru13, Annalisa Chiarenza14, Andrea Visentin15, Adalgisa Condoluci16, Riccardo Moia17, Daniela Pietrasanta18, Giacomo Loseto19, Ugo Consoli20, Ilaria Scortechini21, Anna Grazia Recchia3, Francesca Maria Rossi1, Antonella Zucchetto1, Hamdi Al-Janazreh4, Enrica Antonia Martino2, Ernesto Vigna2, Giovanni Tripepi22, Graziella D'Arrigo22, Sara Galimberti23, Angela Rago24, Ilaria Angeletti25, Annalisa Biagi5, Ilaria Del Giudice6, Riccardo Bomben1, Antonino Neri7, Gilberto Fronza26, Giovanna Cutrona27, Ozrer Jaksic28, Jacopo Olivieri29, Davide Rossi16, Francesco Di Raimondo14, Antonio Cuneo30, Gianluca Gaidano17, Aaron Polliack31, Livio Trentin15, Robin Foà6, Manlio Ferrarini32.   

Abstract

Entities:  

Year:  2021        PMID： 33989438     DOI： 10.1002/ajh.26235

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.

Authors:  Andrea Visentin; Laura Bonaldi; Gian Matteo Rigolin; Francesca Romana Mauro; Annalisa Martines; Federica Frezzato; Stefano Pravato; Leila Romano Gargarella; Maria Antonella Bardi; Maurizio Cavallari; Eleonora Volta; Francesco Cavazzini; Mauro Nanni; Monica Facco; Francesco Piazza; Anna Guarini; Robin Foà; Gianpietro Semenzato; Antonio Cuneo; Livio Trentin
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.